Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Baricitinib is effective and safe for treating alopecia areata.

Topical tacrolimus is safe and effective for skin conditions, but oral tacrolimus has serious side effects.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Croton tiglium application significantly improved hair regrowth in alopecia areata patients.

RTA 408 cream protects mice from radiation skin damage.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Targeting METTL1 may help slow papillary thyroid cancer growth and spread.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Upadacitinib effectively treats pyoderma gangrenosum.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Talquetamab may cause hair loss and skin issues.

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Topical gabapentin was safe and effective for treating scalp symptoms and promoting hair regrowth in cicatricial alopecias.